Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FUJSK
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,449
Award facts
- Contract value 100% obligated
- $49,449.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,449.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials, with an ultimate completion date of October 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled from the company's location in Park Ridge, IL.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through November 2026. The IDC enables the DLA to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Entyvio, a biologic medication used to treat inflammatory bowel conditions, represents one of the specialized pharmaceutical products within the contractor's extensive portfolio that includes prescription medications, biologics, and medical consumables. As a established federal pharmaceutical supplier, DMS Pharmaceutical Group has demonstrated consistent capability in delivering branded and generic drugs, vaccines, and specialty medications to military health facilities since securing SAM.gov registration in 2001.
Quick answers
Who was awarded contract SPE2DB25FUJSK?
SPE2DB25FUJSK was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FUJSK worth?
The government has obligated $49,449 on SPE2DB25FUJSK.
Is contract SPE2DB25FUJSK an order under another contract?
Yes. SPE2DB25FUJSK is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSK competed?
The extent of competition for SPE2DB25FUJSK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award